Necrotizing fasciitis due to community-acquired panton-valentine leukocidin methicillin resistant Staphylococcus aureus;Fascitis necrosante por Staphylococcus aureus resistente a la meticilina adquirido en la comunidad productor de leucocidina de Panton-Valentine

Anales de Pediatria

Volumn 70, Issue 4, 2009, Pages 374-378

  Tobena Rue M ^a   Coll Usandizaga, F ^a   Garcia Fontecha C ^a   Bartolome Comas R ^a   Moraga Llop, F A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Antibiotic treatment; Community Acquired Staphylococcus aureus; Methicillin Resistant; Molecular epidemiology; Necrotizing fasciitis; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRESCHOOL CHILD; TREATMENT OUTCOME;

BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; FASCIITIS, NECROTIZING; HUMANS; INFANT; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 64049096340     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2008.11.027     Document Type: Article

References (20)

1. B.C. Herold, L.C. Immergluck, M.C. Maranan, D.S. Lauderdale, R.E. Gaskin, and S. Boyle-Vavra Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk JAMA 279 1998 593 598
2. CDC Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999 MMWR 48 1999 707 710
3. A. Broseta, F. Chaves, P. Rojo, and J.R. Otero Emergencia de un clon de Staphylococcus aureus resistente a meticilina de origen comunitario en la población pediátrica del sur de Madrid Enferm Infecc Microbiol Clin 24 2006 31 35
4. B. Azkarate, M.A. Von Wichmann de Miguel, I. Arruabarrena, F.J. Martín Rodríguez, J.M. Izquierdo, and F. Rodríguez Arrondo Fascitis necrosante por Streptococcus pyogenes en dos pacientes previamente sanos Enferm Infecc Microbiol Clin 20 2002 173 175
5. E. Cidoncha, J. Urbano, R. Marañón, R. Rodríguez, C. Aritmendi, and A. Parente Fascitis necrosante por Streptococcus pyogenes An Pediatr (Barc) 64 2006 167 169
6. F. Chaves, M. Daskalaki, and J.R. Otero Epidemiología de las infecciones por grampositivos multirresistentes Enferm Infecc Microbiol Clin 26 Supl 2 2008 4 12
7. R.J. Gorwitz A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections Pediatr Infect Dis J 27 2008 1 7
8. G. Loren, F. Perdreau-Remington, G. Rieg, and S. Mehd Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles N Eng J Med 352 2005 1445 1453
9. A. Luque, A. Durán, A. Bregada, A. Frick, and C. Gallés Osteomielitis aguda y neumonía comunitaria por Staphylococcus aureus resistente a meticilina An Pediatr (Barc) 68 2008 373 376
10. C. Pigrau, and J. Barberán Infecciones de piel y partes blandas por grampositivos multirresistentes Enferm Infecc Microbiol Clin 26 Supl 2 2008 21 30
11. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC-convened experts' meeting on management of MRSA in the community. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Disponible en: http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca.html.
12. G.J. Moran, A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, and R.B. Carey Methicillin-resistant S. aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
13. A. Widmer Ceftobiprole: A new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus Clin Infect Dis 46 2008 656 658
14. J. Fergie, and K. Purcel The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections Pediatr Infect Dis J 27 2008 67 68
15. S.T. Micek Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections Clin Infect Dis 45 2007 S184 S190
16. R.C. Moellering Jr Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 2008 1032 1037
17. Z.A. Kanafani, and V.G. Fowler Jr Staphylococcus aureus infections: New challenges from an old pathogen Enferm Infecc Microbiol Clin 24 2006 182 193
18. M.E. Stryjewski, and H.F. Chambers Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus Clin Infect Dis 46 2008 368 377
19. E. Paintsil Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management Curr Opin Pediatr 19 2007 75 82
20. J. Darenberg, N. Ihendyane, J. Sjölin, E. Aufwerber, S. Haidl, and P. Follin Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-bind, placebo-controlled trial Clin Infect Dis 37 2003 333 340